University of Pennsylvania Health System to Equip New Cancer Treatment and Research Center with Technology from Varian Medical Systems | Varian

{ "pageType": "news-article", "title": "University of Pennsylvania Health System to Equip New Cancer Treatment and Research Center with Technology from Varian Medical Systems", "articleDate": "27 de July de 2006", "introText": "", "category": "Oncology" }

University of Pennsylvania Health System to Equip New Cancer Treatment and Research Center with Technology from Varian Medical Systems

PALO ALTO, Calif., July 27 /PRNewswire-FirstCall/ -- The University of Pennsylvania Health System (UPHS), which is building a new world-class cancer treatment and research center, has selected, for its center, advanced cancer radiotherapy treatment technology from Varian Medical Systems (NYSE: VAR), including:

-- four Clinac iX™ accelerators equipped with On-Board Imager®
     devices for image-guided radiotherapy (IGRT), and high-resolution 120-
     leaf multileaf collimators, which are beam shaping devices that make it
     possible to deliver SmartBeam™ IMRT treatments,
  -- an Acuity™ digital imaging device for treatment simulation and
  -- 20 Eclipse® treatment planning workstations for planning all types of
     external beam radiotherapy, including 3-D conformal, intensity-
     modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and
     proton treatments
  -- the xArray™ optical guidance system for ultra-accurate patient
  -- accessories for delivering stereotactic radiosurgery (SRS),
  -- RPM™ respiratory gating for synchronizing imaging and treatment with
     a patient's respiratory cycle, in order to deal with tumor motion
     during treatment, and
  -- the ARIA™ oncology information system for managing administrative
     and clinical information.

These products will be integrated within a new state-of-the-art cancer treatment facility being built as part of the Raymond and Ruth Perelman Center for Advanced Medicine (CAM), a $302 million center now under construction.

"UPHS is committed to providing cancer patients with the best care available anywhere in the world," said Michael J. Dandorph, senior vice president for business development at UPHS. "Our clinicians feel Varian's technology for delivering advanced forms of external-beam photon radiotherapy is unmatched for its power, precision, and versatility in treating the complex cancers we often encounter. The Varian products will enable our clinicians to design and deliver very personalized cancer treatments that zero in on malignancies and spare normal healthy tissues to the extent possible with IMRT technology."

"By assembling this complete set of interconnecting radiotherapy tools from Varian, UPHS is putting together a fully automated and integrated treatment and data network that will speed up processes and enable highly accurate treatments to take place quickly and efficiently," said Dow Wilson, president of Varian's Oncology Systems business. "We are delighted to support UPHS in building one of the most advanced, state-of-the-art cancer treatment centers anywhere in the world."

The new UPHS cancer treatment facility is expected to be ready for clinical use some time in 2008.


Varian Medical Systems, Inc., of Palo Alto, California is the world's leading manufacturer of medical technology for treating cancer with radiotherapy and neurological conditions with radiosurgery. The company is also a premier supplier of X- ray tubes and flat-panel digital subsystems for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 3,600 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world. Additional information is available on the company's web site at .


Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "will," "can," and "possible" constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.

   Spencer Sias, (650) 424-5782
   Meryl Ginsberg, (650) 424-6444

SOURCE: Varian Medical Systems, Inc.

CONTACT: Spencer Sias, +1-650-424-5782 or, or
Meryl Ginsberg, +1-650-424-6444 or, both of Varian
Medical Systems, Inc.

Web site: